Effects of Pregnancy on the Pharmacokinetics of Lamotrigine in Dogs

Authors


Address correspondence and reprint requests to Dr. K. M. Matar at Department of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.

Abstract

Summary: Purpose: This study was designed to evaluate the effects of pregnancy on the kinetics of lamotrigine (LTG).

Methods: Five pregnant dogs were given a daily dose of LTG (100 mg) for a period of 1 week. Two months after parturition, the same subjects were given the LTG dose (100 mg) over the same period. On both occasions, plasma LTG concentrations were determined by a sensitive, high-performance liquid chromatographic (HPLC) method, over a 30-h period after the last dose.

Results: The mean maximum plasma concentration (Cmax), volume of distribution (Vd/F), and oral body clearance (Cl/F) for LTG (± SD) during pregnancy were 7.63 ± 2.46 μg/ml 1.74 ± 0.29 L/kg, and 0.19 ± 0.04 L/h/kg, respectively. After pregnancy, the same variables were 6.12 ± 2.24 μg/ml, 2.36 ± 1.10 L/kg, and 0.30 ± 0.13 L/h/kg, respectively. None of these pharmacokinetic parameters was found to be significantly different between the two groups.

Conclusions: The apparent lack of change in the relevant pharmacokinetic parameters of LTG during pregnancy may indicate that pregnancy has little or no effect on glucuronidation; the principal pathway for the drug's elimination.

Ancillary